Biography
Dr. Sokolow has a broad background in pharmacology and neurobiology of Alzheimer’s disease (AD), with specific training and expertise in molecular biology, clinical pharmacy and pharmacogenomics with emphasis in analyzing secondary data of drug response in the treatment of cognitive symptoms of AD and mild cognitive impairment (MCI). Her current research project focuses on the discovery of genetic polymorphisms associated with response to AD medications, such as donepezil and other acetylcholinesterase inhibitors. Areas of Scholarly Expertise and Interest: Alzheimer’s disease, genetics, pharmacogenomics, pharmacology and therapeutics, biomarkers, calcium signaling pathways.
Publications
A selected list of publications:
Apostolova Liana G, Hwang Kristy S, Avila David, Elashoff David, Kohannim Omid, Teng Edmond, Sokolow Sophie, Jack Clifford R, Jagust William J, Shaw Leslie, Trojanowski John Q, Weiner Michael W, Thompson Paul M, Thompson Paul M
Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures Neurology, 2015; 84(7): 729-37.
Hohendanner Felix, Ljubojević Senka, MacQuaide Niall, Sacherer Michael, Sedej Simon, Biesmans Liesbeth, Wakula Paulina, Platzer Dieter, Sokolow Sophie, Herchuelz André, Antoons Gudrun, Sipido Karin, Pieske Burkert, Heinzel Frank R
Intracellular dyssynchrony of diastolic cytosolic [Ca²⁺] decay in ventricular cardiomyocytes in cardiac remodeling and human heart failure Circulation research, 2013; 113(5): 527-38.
Molinaro Pasquale, Cataldi Mauro, Cuomo Ornella, Viggiano Davide, Pignataro Giuseppe, Sirabella Rossana, Secondo Agnese, Boscia Francesca, Pannaccione Anna, Scorziello Antonella, Sokolow Sophie, Herchuelz André, Di Renzo Gianfranco, Annunziato Lucio
Genetically modified mice as a strategy to unravel the role played by the Na(+)/Ca (2+) exchanger in brain ischemia and in spatial learning and memory deficits Advances in experimental medicine and biology, 2013; 961: 213-22.
Pannaccione Anna, Secondo Agnese, Molinaro Pasquale, D’Avanzo Carla, Cantile Maria, Esposito Alba, Boscia Francesca, Scorziello Antonella, Sirabella Rossana, Sokolow Sophie, Herchuelz André, Di Renzo Gianfranco, Annunziato Lucio
A new concept: Aβ1-42 generates a hyperfunctional proteolytic NCX3 fragment that delays caspase-12 activation and neuronal death The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012; 32(31): 10609-17.
Boscia F, D’Avanzo C, Pannaccione A, Secondo A, Casamassa A, Formisano L, Guida N, Sokolow Sophie, Herchuelz André, Annunziato L
Silencing or knocking out the Na(+)/Ca(2+) exchanger-3 (NCX3) impairs oligodendrocyte differentiation Cell death and differentiation, 2012; 19(4): 562-72.
Ringman John M, Schulman Howard, Becker Chris, Jones Ted, Bai Yuchen, Immermann Fred, Cole Gregory, Sokolow Sophie, Gylys Karen, Geschwind Daniel H, Cummings Jeffrey L, Wan Hong I
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations Archives of neurology, 2012; 69(1): 96-104.
Nguidjoe Evrard, Sokolow Sophie, Bigabwa Serge, Pachera Nathalie, D’Amico Eva, Allagnat Florent, Vanderwinden Jean-Marie, Sener Abdullah, Manto Mario, Depreter Marianne, Mast Jan, Joanny Geraldine, Montanya Eduard, Rahier Jacques, Cardozo Alessandra K, Eizirik Décio L, Schurmans Stéphane, Herchuelz André
Heterozygous inactivation of the Na/Ca exchanger increases glucose-induced insulin release, β-cell proliferation, and mass Diabetes, 2011; 60(8): 2076-85.
Molinaro Pasquale, Viggiano Davide, Nisticò Robert, Sirabella Rossana, Secondo Agnese, Boscia Francesca, Pannaccione Anna, Scorziello Antonella, Mehdawy Bisan, Sokolow Sophie, Herchuelz André, Di Renzo Gianfranco F, Annunziato Lucio
Na+ -Ca2+ exchanger (NCX3) knock-out mice display an impairment in hippocampal long-term potentiation and spatial learning and memory The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011; 31(20): 7312-21.
Sokolow Sophie, Luu Sanh H, Headley Alison J, Hanson Alecia Y, Kim Taeree, Miller Carol A, Vinters Harry V, Gylys Karen H
High levels of synaptosomal Na(+)-Ca(2+) exchangers (NCX1, NCX2, NCX3) co-localized with amyloid-beta in human cerebral cortex affected by Alzheimer’s disease Cell calcium, 2011; 49(4): 208-16.
Verwey N A, van der Flier W M, Blennow K, Clark C, Sokolow S, De Deyn P P, Galasko D, Hampel H, Hartmann T, Kapaki E, Lannfelt L, Mehta P D, Parnetti L, Petzold A, Pirttila T, Saleh L, Skinningsrud A, Swieten J C V, Verbeek M M, Wiltfang J, Younkin S, Scheltens P, Blankenstein M A
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer’s disease Annals of clinical biochemistry, 2009; 46(Pt 3): 235-40.
Ringman J M, Younkin S G, Pratico D, Seltzer W, Cole G M, Geschwind D H, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario E R, Gylys K H, Varpetian A, Medina L D, Cummings J L
Biochemical markers in persons with preclinical familial Alzheimer disease Neurology, 2008; 71(2): 85-92.
Molinaro Pasquale, Cuomo Ornella, Pignataro Giuseppe, Boscia Francesca, Sirabella Rossana, Pannaccione Anna, Secondo Agnese, Scorziello Antonella, Adornetto Annagrazia, Gala Rosaria, Viggiano Davide, Sokolow Sophie, Herchuelz Andre, Schurmans Stèphane, Di Renzo Gianfranco, Annunziato Lucio
Targeted disruption of Na+/Ca2+ exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008; 28(5): 1179-84.